Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide radium ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

FABA, IIL & ABF launch Finishing School Programme in Hyderabad giving a boost to lifesciences career: Our Bureau, Bengaluru Thursday, May 8, 2025, 17:15 Hrs [IST] In a step toward ...

Six posters presented at the American Association for Cancer Research (AACR) annual meetingAppointment of Dr. Sabeen Mekan as Senior Vice President, Clinical DevelopmentReported $321.6 million in cash ...

Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced the completion of ISO 10993 biocompatibility testing and human ...

Discover the Top 12 American Skincare Brands [Update 2025] dominating the beauty scene with innovative, effective products ...

“Asking Stanford” is a series of small stories from Stanford students that comes together to highlight the diversity of ...

South by Southwest Festival goers, local leaders and Longhorns recently gathered at UT's Hook 'Em House at Antone's to hear from an esteemed panel ...

Acquisition of approximately 71% stake in Kokomodo Ltd. <li /> Acquisition uniquely combines Pluri's mass-scale cell production experti ...